Consolidated Balance Sheets (USD $)	Jun. 30, 2012	Dec. 31, 2011
Cash	$ 13,007	$ 1,436
Receivable-related party	266	3,765
Total current assets	13,273	5,201
Office and laboratory equipment and leasehold improvements	1,167,163	766,851
Less: Accumulated depreciation	(733,565)	(729,237)
Total property and equipment, net	433,598	37,614
Other assets	7,000	7,000
TOTAL ASSETS	453,871	49,815
Accounts payable	1,019,606	656,703
Accounts payable-related party		361
Accrued expenses	1,936,873	1,447,282
Notes payable	10,800	10,800
Convertible notes payable	700,846	307,220
Loan from shareholder	645,419	645,419
Total current liabilities	4,313,544	3,067,785
Common stock	24,960	23,710
Additional paid-in capital	17,504,332	17,480,582
Deficit accumulated during the development stage	(21,400,644)	(20,555,008)
Accumulated other comprehensive loss	(12,936)
Total stockholders' deficit of Genethera, Inc.	(3,868,873)	(3,035,301)
Non-controlling interest	9,200	17,331
Total stockholders' deficit	(3,859,673)	(3,017,970)
TOTAL LIABILITIES & STOCKHOLDERS' DEFICIT	453,871	49,815
Series A Preferred Stock
Preferred stock	5	5
Series B Preferred Stock
Preferred stock	$ 15,410	$ 15,410